Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.

Détails

ID Serval
serval:BIB_F163EA163C89
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.
Périodique
Future oncology
Auteur(s)
Sun X.S., Michel C., Babin E., De Raucourt D., Péchery A., Gherga E., Géry B., Florescu C., Bourhis J., Thariat J.
ISSN
1744-8301 (Electronic)
ISSN-L
1479-6694
Statut éditorial
Publié
Date de publication
04/2018
Peer-reviewed
Oui
Volume
14
Numéro
9
Pages
877-889
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Median survival for recurrent/metastatic head and neck squamous cell cancer (HNSCC) patients is about 10 months after first-line best systemic treatment. We aimed to assess current approaches of oligometastatic HNSCC patients by the analysis of current concept and published data (1995-2017) in this population. Five-year survival rates are over 20% in selected patients who undergo metastasis-directed therapy by either surgery or stereotactic irradiation. Human papillomavirus(+) HNSCC patients have more disseminated metastases but respond more favorably and also benefit from ablative treatments. Treatments of oligometastases are expanding rapidly. Unmet needs include revised imaging follow-up strategies to detect metastases earlier, identification of predictive noninvasive biomarkers for treatment guidance, assessment and corrections of biases in current studies and randomized clinical trials.
Mots-clé
Biomarkers, Tumor/genetics, Carcinoma, Squamous Cell/drug therapy, Carcinoma, Squamous Cell/genetics, Carcinoma, Squamous Cell/radiotherapy, Carcinoma, Squamous Cell/surgery, Head and Neck Neoplasms/drug therapy, Head and Neck Neoplasms/genetics, Head and Neck Neoplasms/radiotherapy, Head and Neck Neoplasms/surgery, Humans, Neoplasm Metastasis, Neoplasm Recurrence, Local/drug therapy, Neoplasm Recurrence, Local/genetics, Neoplasm Recurrence, Local/radiotherapy, Neoplasm Recurrence, Local/surgery, Radiosurgery, Randomized Controlled Trials as Topic, ablative treatment, head and neck cancer, immunotherapy, metastasectomy, metastases, metastasis-directed treatment, oligometastases, stereotactic irradiation
Pubmed
Web of science
Création de la notice
29/03/2018 18:50
Dernière modification de la notice
20/08/2019 17:18
Données d'usage